Creutzfeldt-Jakob \[croytsʹfelt-jakʺob\] Disease
================================================

In 1920, German neuropathologist Alfons Maria Jakob ([Figure](#F1){ref-type="fig"}) described a series of 6 patients with spasticity and progressive dementia associated with neural degeneration. Shortly thereafter, in 1921, another German neuropathologist, Hans Gerhardt Creutzfeldt ([Figure](#F1){ref-type="fig"}), independently published a similar case. Jakob gave credit to Creutzfeldt for describing the syndrome first, without realizing he had also uncovered the new syndrome. Walther Spielmeyer first used the term "Creutzfeldt-Jakob disease" (CJD) in 1922. CJD occurs worldwide as a rare, sporadic disease, with genetic and iatrogenic forms ([Figure](#F1){ref-type="fig"}). A zoonotic form, variant CJD (vCJD), is caused by infection with a prion derived from bovines and occurs predominantly in the United Kingdom.

![(L--R) Hans Gerhard Creutzfeldt (1885--1964; Alfons Maria Jakob (1884--1931); Creutzfeldt--Jakob disease, cerebrum hematoxylin and eosin staining showing spongiform encephalophathy. Images reproduced from Foundations of Virology, 2012, courtesy Frederick A. Murphy.](ET-2306-F){#F1}

This issue of Emerging Infectious Diseases' long-running *Etymologia* series is dedicated to the memory of Richard T. Johnson, MD (1931--2015), the leading prion disease authority in the United States for many years and great friend of CDC's infectious disease programs, so many of which involve central nervous system disorders.
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